BioInvent International AB (publ) (STO:BINV)
22.60
+0.40 (1.80%)
Jul 24, 2026, 5:29 PM CET
STO:BINV Balance Sheet
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 356.39 | 356.17 | 434.83 | 259.55 | 515.05 | 910.76 |
Short-Term Investments | 100.09 | 236.58 | 432.33 | 809.15 | 502.43 | 172.07 |
Cash & Short-Term Investments | 456.48 | 592.75 | 867.16 | 1,069 | 1,017 | 1,083 |
Cash Growth | -38.50% | -31.64% | -18.86% | 5.03% | -6.04% | 48.48% |
Accounts Receivable | 37.75 | 1.69 | 8.27 | 11.93 | 15.78 | 0.37 |
Other Receivables | - | 8.79 | 16.89 | 20.73 | 20.8 | 9.02 |
Total Trade Receivables | 37.75 | 10.47 | 25.16 | 32.66 | 36.58 | 9.39 |
Inventory | 11.48 | 12.29 | 10.97 | 11.84 | 11.51 | 16.85 |
Other Current Assets | - | 22.18 | 39.93 | 20.06 | 18.5 | 6.95 |
Total Current Assets | 505.7 | 637.69 | 943.21 | 1,133 | 1,084 | 1,116 |
Net Property, Plant & Equipment | 29.26 | 33.51 | 46.02 | 52.66 | 52.01 | 49.08 |
Long-Term Investments | - | - | - | 214.25 | 576.14 | 282.21 |
Total Assets | 534.96 | 671.2 | 989.24 | 1,400 | 1,712 | 1,447 |
Accounts Payable | - | 52.34 | 49.1 | 29.19 | 41.35 | 19.72 |
Accrued Expenses | - | 45.99 | 30.22 | 32.25 | 31.97 | 23.2 |
Current Portion of Leases | 5.52 | 7.37 | 9.2 | 8.71 | 8.19 | 6.84 |
Other Current Liabilities | 89.6 | 6.73 | 6.7 | 5.77 | 5.81 | 9.04 |
Total Current Liabilities | 95.12 | 112.43 | 95.21 | 75.92 | 87.32 | 58.79 |
Long-Term Leases | 0.73 | 1.16 | 8.22 | 14.54 | 18.77 | 21.53 |
Total Long-Term Liabilities | 0.73 | 1.16 | 8.22 | 14.54 | 18.77 | 21.53 |
Total Liabilities | 95.85 | 113.59 | 103.42 | 90.45 | 106.09 | 80.32 |
Common Stock | - | 13.16 | 13.16 | 13.16 | 12.99 | 11.69 |
Additional Paid-in Capital | - | 3,759 | 3,759 | 3,759 | 3,728 | 3,450 |
Accumulated Other Comprehensive Income | - | 0 | 0 | 0 | 0 | 0 |
Retained Earnings | - | -3,215 | -2,887 | -2,463 | -2,135 | -2,095 |
Shareholders' Equity | 439.11 | 557.62 | 885.82 | 1,310 | 1,606 | 1,367 |
Total Liabilities & Equity | 534.96 | 671.2 | 989.24 | 1,400 | 1,712 | 1,447 |
Total Debt | 6.26 | 8.53 | 17.41 | 23.24 | 26.96 | 28.37 |
Net Cash (Debt) | 450.22 | 584.22 | 849.75 | 1,045 | 990.52 | 1,054 |
Net Cash Growth | -22.94% | -31.25% | -18.72% | 5.55% | -6.06% | 46.93% |
Net Cash Per Share | 6.83 | 8.88 | 12.91 | 15.90 | 16.10 | 19.47 |
Book Value | 439.11 | 557.62 | 885.82 | 1,310 | 1,606 | 1,367 |
Book Value Per Share | 6.66 | 8.47 | 13.46 | 19.91 | 26.11 | 25.24 |
Tangible Book Value | 439.11 | 557.62 | 885.82 | 1,310 | 1,606 | 1,367 |
Tangible Book Value Per Share | 6.66 | 8.47 | 13.46 | 19.91 | 26.11 | 25.24 |